Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tauro-obeticholic acid, a farnesoid X receptor (FXR) agonist and semisynthetic derivative of chenodeoxycholic acid, is an active metabolite of obeticholic acid. This compound undergoes taurine conjugation in the liver to form from obeticholic acid and can be reconverted to its original form by intestinal microflora.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 397.00 | |
5 mg | 35 days | $ 1,620.00 |
Description | Tauro-obeticholic acid, a farnesoid X receptor (FXR) agonist and semisynthetic derivative of chenodeoxycholic acid, is an active metabolite of obeticholic acid. This compound undergoes taurine conjugation in the liver to form from obeticholic acid and can be reconverted to its original form by intestinal microflora. |
Synonyms | Tauro-6-Ethylchenodeoxycholic Acid, Tauro-6-Ethyl-CDCA, Obeticholic Acid Taurine Conjugate, Tauro-OCA, T-ECDCA |
Molecular Weight | 549.74 |
Formula | C28H48NO6S.Na |
CAS No. | 2278141-79-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 20 mg/ml
PBS pH 7.2: 2 mg/ml
DMSO: 20 mg/ml
DMF: 20 mg/ml
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tauro-Obeticholic Acid sodium 2278141-79-8 Tauro-6-Ethylchenodeoxycholic Acid Tauro-6-Ethyl-CDCA Obeticholic Acid Taurine Conjugate Tauro-OCA T-ECDCA inhibitor inhibit